Michael A Sugarman1,2, Michael L Alosco1,3, Yorghos Tripodis1,4, Eric G Steinberg1, Robert A Stern1,3,5,6. 1. Boston University Alzheimer's Disease Center, Boston, MA, USA. 2. Department of Psychology, Bedford Veterans Affairs Medical Center, Boston, MA, USA. 3. Department of Neurology, Boston University School of Medicine, Boston, MA, USA. 4. Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA. 5. Department of Neurosurgery, Boston University School of Medicine, Boston, MA, USA. 6. Department of Anatomy and Neurobiology, Boston University School of Medicine, Boston, MA, USA.
Abstract
BACKGROUND: Mild cognitive impairment (MCI) is an intermediate diagnosis between normal cognition (NC) and dementia, including Alzheimer's disease (AD) dementia. However, MCI is heterogeneous; many individuals subsequently revert to NC while others remain stable at MCI for several years. Identifying factors associated with this diagnostic instability could assist in defining clinical populations and determining cognitive prognoses. OBJECTIVE: The current study examined whether neuropsychiatric symptoms could partially account for the temporal instability in cognitive diagnoses. METHOD: The sample included 6,763 participants from the National Alzheimer's Coordinating Center Uniform Data Set. All participants had NC at baseline, completed at least two follow-up visits (mean duration: 5.5 years), and had no recent neurological conditions. Generalized linear models estimated by generalized estimating equations examined associations between changes in cognitive diagnoses and symptoms on the Neuropsychiatric Inventory Questionnaire (NPI-Q) and Geriatric Depression Scale (GDS-15). RESULTS: 1,121 participants converted from NC to MCI; 324 reverted back to NC and 242 progressed to AD dementia. Higher symptoms on the GDS-15 and circumscribed symptom domains on the NPI-Q were associated with conversion from NC to MCI and a decreased likelihood of reversion from MCI to NC. Individuals with higher symptoms on NPI-Q Hyperactivity and Mood items were more likely to progress to AD dementia. DISCUSSION: The temporal instability of MCI can be partially explained by neuropsychiatric symptoms. Individuals with higher levels of specific symptoms are more likely to progress to AD dementia and less likely to revert to NC. Identification and treatment of these symptoms might support cognitive functioning in older adults.
BACKGROUND: Mild cognitive impairment (MCI) is an intermediate diagnosis between normal cognition (NC) and dementia, including Alzheimer's disease (AD) dementia. However, MCI is heterogeneous; many individuals subsequently revert to NC while others remain stable at MCI for several years. Identifying factors associated with this diagnostic instability could assist in defining clinical populations and determining cognitive prognoses. OBJECTIVE: The current study examined whether neuropsychiatric symptoms could partially account for the temporal instability in cognitive diagnoses. METHOD: The sample included 6,763 participants from the National Alzheimer's Coordinating Center Uniform Data Set. All participants had NC at baseline, completed at least two follow-up visits (mean duration: 5.5 years), and had no recent neurological conditions. Generalized linear models estimated by generalized estimating equations examined associations between changes in cognitive diagnoses and symptoms on the Neuropsychiatric Inventory Questionnaire (NPI-Q) and Geriatric Depression Scale (GDS-15). RESULTS: 1,121 participants converted from NC to MCI; 324 reverted back to NC and 242 progressed to AD dementia. Higher symptoms on the GDS-15 and circumscribed symptom domains on the NPI-Q were associated with conversion from NC to MCI and a decreased likelihood of reversion from MCI to NC. Individuals with higher symptoms on NPI-Q Hyperactivity and Mood items were more likely to progress to AD dementia. DISCUSSION: The temporal instability of MCI can be partially explained by neuropsychiatric symptoms. Individuals with higher levels of specific symptoms are more likely to progress to AD dementia and less likely to revert to NC. Identification and treatment of these symptoms might support cognitive functioning in older adults.
Authors: M A Butters; J T Becker; R D Nebes; M D Zmuda; B H Mulsant; B G Pollock; C F Reynolds Journal: Am J Psychiatry Date: 2000-12 Impact factor: 18.112
Authors: Duane L Beekly; Erin M Ramos; Gerald van Belle; Woodrow Deitrich; Amber D Clark; Mary E Jacka; Walter A Kukull Journal: Alzheimer Dis Assoc Disord Date: 2004 Oct-Dec Impact factor: 2.703
Authors: John C Morris; Sandra Weintraub; Helena C Chui; Jeffrey Cummings; Charles Decarli; Steven Ferris; Norman L Foster; Douglas Galasko; Neill Graff-Radford; Elaine R Peskind; Duane Beekly; Erin M Ramos; Walter A Kukull Journal: Alzheimer Dis Assoc Disord Date: 2006 Oct-Dec Impact factor: 2.703
Authors: A Lynn Snow; Mark E Kunik; Victor A Molinari; Claudia A Orengo; Rachelle Doody; David P Graham; Margaret P Norris Journal: J Am Geriatr Soc Date: 2005-03 Impact factor: 5.562
Authors: B Winblad; K Palmer; M Kivipelto; V Jelic; L Fratiglioni; L-O Wahlund; A Nordberg; L Bäckman; M Albert; O Almkvist; H Arai; H Basun; K Blennow; M de Leon; C DeCarli; T Erkinjuntti; E Giacobini; C Graff; J Hardy; C Jack; A Jorm; K Ritchie; C van Duijn; P Visser; R C Petersen Journal: J Intern Med Date: 2004-09 Impact factor: 8.989
Authors: Oscar L Lopez; James T Becker; Robert A Sweet; William Klunk; Daniel I Kaufer; Judith Saxton; Miguel Habeych; Steven T DeKosky Journal: J Neuropsychiatry Clin Neurosci Date: 2003 Impact factor: 2.198
Authors: Isabelle Pelcher; Christian Puzo; Yorghos Tripodis; Hugo J Aparicio; Eric G Steinberg; Alyssa Phelps; Brett Martin; Joseph N Palmisano; Elizabeth Vassey; Cutter Lindbergh; Ann C McKee; Thor D Stein; Ronald J Killiany; Rhoda Au; Neil W Kowall; Robert A Stern; Jesse Mez; Michael L Alosco Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Brandon Frank; Madeline Ally; Bailee Brekke; Henrik Zetterberg; Kaj Blennow; Michael A Sugarman; Nicholas J Ashton; Thomas K Karikari; Yorghos Tripodis; Brett Martin; Joseph N Palmisano; Eric G Steinberg; Irene Simkina; Katherine W Turk; Andrew E Budson; Maureen K O'Connor; Rhoda Au; Lee E Goldstein; Gyungah R Jun; Neil W Kowall; Thor D Stein; Ann C McKee; Ronald Killiany; Wei Qiao Qiu; Robert A Stern; Jesse Mez; Michael L Alosco Journal: Alzheimers Dement Date: 2021-12-02 Impact factor: 16.655
Authors: Mary Ganguli; Yichen Jia; Tiffany F Hughes; Beth E Snitz; Chung-Chou H Chang; Sarah B Berman; Kevin J Sullivan; M Ilyas Kamboh Journal: J Am Geriatr Soc Date: 2018-11-16 Impact factor: 5.562
Authors: Jahnavi Mundluru; Abdul Subhan; Tsz Wai Bentley Lo; Nathan Churchill; Luis Fornazzari; David G Munoz; Tom A Schweizer; Corinne E Fischer Journal: J Neurotrauma Date: 2020-10-20 Impact factor: 5.269
Authors: Erin M Jonaitis; Rebecca L Koscik; Lindsay R Clark; Yue Ma; Tobey J Betthauser; Sara E Berman; Samantha L Allison; Kimberly D Mueller; Bruce P Hermann; Carol A Van Hulle; Bradley T Christian; Barbara B Bendlin; Kaj Blennow; Henrik Zetterberg; Cynthia M Carlsson; Sanjay Asthana; Sterling C Johnson Journal: Alzheimers Dement (Amst) Date: 2019-01-11